NCT04473781
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
Clinical trial condition
Carcinoma, Renal Cell
Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.
1,363 public trials
252 recruiting studies
Carcinoma, Renal Cell trial results
NCT04485013
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adnexal Diseases, +70 more
- Locations
-
- Arizona Oncology Associates Tucson, Arizona, United States
- University of Southern California Los Angeles, California, United States
- Hoag Memorial Hospital Newport Beach, California, United States
- Rocky Mountain Cancer Centers Denver, Colorado, United States
NCT05641935
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States
NCT06724159
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Complejo Hospitalario Universitario de Albacete Albacete, Spain
- Hospital General Universitario de Alicante Alicante, Spain
- Hospital Universitario Torrecárdenas Almería, Andalusia, Spain
- Hospital Universitario Reina Sofía Córdoba, Andalusia, Spain
NCT05890781
- Conditions
- Adenocarcinoma, Brain Diseases, Brain Neoplasms, +30 more
- Locations
-
- Gustave Roussy Villejuif, France
- Hopital Necker Paris, Île-de-France Region, France
NCT06242470
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +102 more
- Locations
-
- The Angeles Clinic and Research Institute Los Angeles, California, United States
- START Midwest Grand Rapids, Michigan, United States
- START-New York Long Island Lake Success, New York, United States
- Providence Cancer Institute Portland, Oregon, United States
Recruiting
Iparomlimab and Tuvonralimab (QL1706) Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC
NCT07389629
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, China
NCT07386158
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Other (Non U.s.), China
NCT04623502
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +29 more
- Locations
-
- University of Texas Southwestern Medical Center Dallas, Texas, United States
Recruiting
SABR Combined With Targeted Therapy and Anti-PD-1 for Recurrent or Metastatic Renal Cancer
NCT06583070
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- Peking University First Hospital Beijing, Beijing Municipality, China
- Peking University Third Hospital Beijing, Beijing Municipality, China